Literature DB >> 19701491

Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome.

Arthur J Moss1, Ilan Goldenberg.   

Abstract

Entities:  

Keywords:  arrhythmia; genetics; long-QT syndrome; risk factors

Mesh：

Year:  2008        PMID： 19701491      PMCID： PMC2729934          DOI： 10.1161/CIRCEP.108.796599

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


× No keyword cloud information.
  43 in total

Review 1.  Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.

Authors:  C T January; Q Gong; Z Zhou
Journal:  J Cardiovasc Electrophysiol       Date:  2000-12

2.  Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

Authors:  Arthur J Moss; Wojciech Zareba; Elizabeth S Kaufman; Eric Gartman; Derick R Peterson; Jesaia Benhorin; Jeffrey A Towbin; Mark T Keating; Silvia G Priori; Peter J Schwartz; G Michael Vincent; Jennifer L Robinson; Mark L Andrews; Changyong Feng; W Jackson Hall; Aharon Medina; Li Zhang; Zhiqing Wang
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

3.  Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.

Authors:  J R Windle; R C Geletka; A J Moss; W Zareba; D L Atkins
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-04       Impact factor: 1.468

4.  Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.

Authors:  Yejia Song; John C Shryock; Lin Wu; Luiz Belardinelli
Journal:  J Cardiovasc Pharmacol       Date:  2004-08       Impact factor: 3.105

5.  Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Authors:  Wojciech Zareba; Arthur J Moss; Gloria Sheu; Elizabeth S Kaufman; Silvia Priori; G Michael Vincent; Jeffrey A Towbin; Jesaia Benhorin; Peter J Schwartz; Carlo Napolitano; W Jackson Hall; Mark T Keating; Ming Qi; Jennifer L Robinson; Mark L Andrews
Journal:  J Cardiovasc Electrophysiol       Date:  2003-11

6.  Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.

Authors:  Peter J Schwartz; Silvia G Priori; Marina Cerrone; Carla Spazzolini; Attilio Odero; Carlo Napolitano; Raffaella Bloise; Gaetano M De Ferrari; Catherine Klersy; Arthur J Moss; Wojciech Zareba; Jennifer L Robinson; W Jackson Hall; Paul A Brink; Lauri Toivonen; Andrew E Epstein; Cuilan Li; Dayi Hu
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

7.  Implantable cardioverter defibrillator in high-risk long QT syndrome patients.

Authors:  Wojciech Zareba; Arthur J Moss; James P Daubert; W Jackson Hall; Jennifer L Robinson; Mark Andrews
Journal:  J Cardiovasc Electrophysiol       Date:  2003-04

8.  Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan.

Authors:  Wataru Shimizu; Minoru Horie; Seiko Ohno; Kotoe Takenaka; Masato Yamaguchi; Masami Shimizu; Takashi Washizuka; Yoshifusa Aizawa; Kazufumi Nakamura; Tohru Ohe; Takeshi Aiba; Yoshihiro Miyamoto; Yasunao Yoshimasa; Jeffrey A Towbin; Silvia G Priori; Shiro Kamakura
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

9.  A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations.

Authors:  Susan P Etheridge; Steven J Compton; Martin Tristani-Firouzi; Jay W Mason
Journal:  J Am Coll Cardiol       Date:  2003-11-19       Impact factor: 24.094

10.  Risk stratification in the long-QT syndrome.

Authors:  Silvia G Priori; Peter J Schwartz; Carlo Napolitano; Raffaella Bloise; Elena Ronchetti; Massimiliano Grillo; Alessandro Vicentini; Carla Spazzolini; Janni Nastoli; Georgia Bottelli; Roberta Folli; Donata Cappelletti
Journal:  N Engl J Med       Date:  2003-05-08       Impact factor: 91.245
View more
  8 in total

1.  LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.

Authors:  Ademuyiwa S Aromolaran; Prakash Subramanyam; Donald D Chang; William R Kobertz; Henry M Colecraft
Journal:  Cardiovasc Res       Date:  2014-10-24       Impact factor: 10.787

Review 2.  Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.

Authors:  Saagar Mahida; Andrew J Hogarth; Campbell Cowan; Muzahir H Tayebjee; Lee N Graham; Christopher B Pepper
Journal:  J Interv Card Electrophysiol       Date:  2013-03-21       Impact factor: 1.900

3.  [Genetic testing in hereditary arrythmia syndromes today and in the future].

Authors:  Britt-Maria Beckmann; Stefan Kääb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-20

Review 4.  Genetics of long QT syndrome.

Authors:  David J Tester; Michael J Ackerman
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

5.  Risk stratification in young patients with channelopathies.

Authors:  N Sreeram; U Trieschmann; M Khalil; M Emmel
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

6.  Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome.

Authors:  Sandeep S Hothi; Glyn Thomas; Matthew J Killeen; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2009-05-09       Impact factor: 3.657

7.  Genetic testing for long QT syndrome and the category of cardiac ion channelopathies.

Authors:  Stephen M Modell; David J Bradley; Michael H Lehmann
Journal:  PLoS Curr       Date:  2012-05-03

Review 8.  The congenital long QT syndrome Type 3: An update.

Authors:  Andrés Ricardo Pérez-Riera; Raimundo Barbosa-Barros; Rodrigo Daminello Raimundo; Marianne Penachini da Costa de Rezende Barbosa; Isabel Cristina Esposito Sorpreso; Luiz Carlos de Abreu
Journal:  Indian Pacing Electrophysiol J       Date:  2017-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.